Question 1

What are the potential benefits of NEOD001 compared to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis clinical trial (NCT02632786). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my heart function be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis clinical trial (NCT02632786). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from NEOD001?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis clinical trial (NCT02632786). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis clinical trial (NCT02632786). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis clinical trial (NCT02632786). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis clinical trial (NCT02632786). Contact the study team or your healthcare provider for specific answers.

What this study is about